中交地產(000736.SZ):擬在不超30億元總規模內開展資產支持票據
格隆匯2月11日丨中交地產(000736.SZ)公佈,公司為拓寬融資渠道,優化資產結構,擬在銀行間債券市場發行供應鏈金融資產支持票據(具體名稱以實際確定為準,“資產支持票據”)。
註冊/備案及發行規模:此次擬在不超過人民幣30億元的總規模內開展資產支持票據,可在上述額度內分期發行,具體發行規模以獲准發行金額為準。
產品期限:各期資產支持票據存續期預計不超過1年,具體期限將以資產支持票據發行文件約定為準。
通過開展資產支持票據業務,可以延長公司應付賬款的付款期限,有效緩解公司短期現金流壓力,優化負債結構。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.